{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:43:14Z","timestamp":1793515394140,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/09215-7"],"award-info":[{"award-number":["2012\/09215-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We aimed to evaluate the effects of different therapeutic options to prevent the evolution of vaginal stenosis after pelvic radiotherapy in women with cervical cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>open-label randomized clinical trial of 195 women, stage I-IIIB, aged 18\u201375\u2009years, using topical estrogen (66), topical testosterone (34), water-based intimate lubricant gel (66), and vaginal dilators (29) to assess the incidence and severity of vaginal stenosis after radiotherapy at UNICAMP-Brazil, from January\/2013 to May\/2018. The main outcome measure was vaginal stenosis assessed using the Common Terminology Criteria for Adverse Events (CTCAE) scale and percental changes in vaginal volume. The women were evaluated at four different times: shortly after the end of radiotherapy, and four, eight, and 12\u2009months after the beginning of the intervention. Statistical analysis was carried out using Symmetry test, Kruskal-Wallis test and multiple regression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>the mean age of women was 46.78 (\u00b113.01) years, 61,03% were premenopausal and 73,84% had stage IIB-IIIB tumors. The mean reduction in vaginal volume in the total group was 25.47%, with similar worsening in the four treatment groups with no statistical difference throughout the intervention period. There was worsening of vaginal stenosis evaluated by CTCAE scale after 1\u2009year in all groups (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), except for the users of vaginal dilator (<jats:italic>p<\/jats:italic>\u2009=\u20090.37).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>there was a reduction in vaginal volume in all treatment groups analyzed, with no significant difference between them. However, women who used vaginal dilators had a lower frequency and severity of vaginal stenosis assessed by the CTCAE scale after one year of treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Brazilian Registry of Clinical Trials, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ensaiosclinicos.gov.br\/rg\/RBR-23w5fv\">RBR-23w5fv<\/jats:ext-link>. Registered 10 January 2017 - Retrospectively registered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08274-w","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T06:04:41Z","timestamp":1623305081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Jumara","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Francisca","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Celia","family":"Grion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facia","family":"Costa-Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8837-8061","authenticated-orcid":false,"given":"Luiz Francisco","family":"Baccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"8274_CR1","volume-title":"GLOBOCAN 2018, Cancer today","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, et al. GLOBOCAN 2018, Cancer today. Lyon: IARC; 2018. (IARC CancerBase, 15). Available at: http:\/\/publications.iarc.fr\/Databases\/Iarc-Cancerbases. Accessed 19 Dec 2019"},{"key":"8274_CR2","unstructured":"World Health Organization. International Agency for Research on Cancer: GLOBOCAN; 2018. Available at: https:\/\/gco.iarc.fr\/today\/online-analysis-table. Accessed 29 Dec 2019"},{"key":"8274_CR3","volume-title":"Estimate\/2018 \u2013 Cancer Incidence in Brazil","author":"Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva\/ Minist\u00e9rio da Sa\u00fade (Brasil)","year":"2018","unstructured":"Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva\/ Minist\u00e9rio da Sa\u00fade (Brasil). Estimate\/2018 \u2013 Cancer Incidence in Brazil. 2018. Available at: http:\/\/www1.inca.gov.br\/estimativa\/2018\/estimativa-2018.pdf. Accessed 29 Dec 2019."},{"key":"8274_CR4","unstructured":"Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva\/ Minist\u00e9rio da Sa\u00fade (Brasil). Atlas da Mortalidade. Available at: https:\/\/mortalidade.inca.gov.br\/MortalidadeWeb\/. Accessed 29 Dec 2019."},{"issue":"35","key":"8274_CR5","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","volume":"26","author":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration","year":"2008","unstructured":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26(35):5802\u201312.","journal-title":"J Clin Oncol"},{"issue":"1","key":"8274_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.brachy.2016.09.011","volume":"16","author":"J Karlsson","year":"2017","unstructured":"Karlsson J, Dreifaldt AC, Mordhorst LB, Sorbe B. Differences in outcome for cervical cancer patients treated with or without brachytherapy. Brachytherapy. 2017;16(1):133\u201340. https:\/\/doi.org\/10.1016\/j.brachy.2016.09.011.","journal-title":"Brachytherapy"},{"issue":"6","key":"8274_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1200\/JCO.2013.50.1205","volume":"32","author":"AC Zuliani","year":"2014","unstructured":"Zuliani AC, Esteves SCB, Teixeira LC, Teixeira JC, Souza GA, Sarian LO. Concomitant Cisplatin plus radiotherapy and high\u2013dose-rate brachytherapy versus radiotherapy alone for stage IIIB Epidermoid cervical Cancer: a randomized controlled trial. J Clin Oncol. 2014;32(6):542\u20137. https:\/\/doi.org\/10.1200\/JCO.2013.50.1205.","journal-title":"J Clin Oncol"},{"issue":"4","key":"8274_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/jamaoncol.2017.5179","volume":"4","author":"S Shrivastava","year":"2018","unstructured":"Shrivastava S, Mahantshetty U, Engineer R, Chopra S, Hawalda R, Hande V, et al. Cisplatin Chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix. A Randomized Clinical Trial. JAMA Oncol. 2018;4(4):506\u201313. https:\/\/doi.org\/10.1001\/jamaoncol.2017.5179.","journal-title":"JAMA Oncol"},{"issue":"2","key":"8274_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/1097-0142(197208)30:2<426::AID-CNCR2820300219>3.0.CO;2-M","volume":"30","author":"P Hartman","year":"1972","unstructured":"Hartman P, Diddle AW. Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri. Cancer. 1972;30(2):426\u20139. https:\/\/doi.org\/10.1002\/1097-0142(197208)30:2<426::AID-CNCR2820300219>3.0.CO;2-M.","journal-title":"Cancer"},{"issue":"1","key":"8274_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijrobp.2014.01.032","volume":"89","author":"K Kirchheiner","year":"2014","unstructured":"Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Westerveld H, Haie-Meder C, et al. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo) therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys. 2014;89(1):88\u201395. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.01.032.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"8274_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0002-9378(74)90031-3","volume":"119","author":"M Abitbol","year":"1974","unstructured":"Abitbol M, Davenport JH. Sexual dysfunction after therapy for cervical carcinoma. Am J Obstet Gynaecol. 1974;119(2):181\u20139. https:\/\/doi.org\/10.1016\/0002-9378(74)90031-3.","journal-title":"Am J Obstet Gynaecol"},{"issue":"2","key":"8274_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0360-3016(94)E0139-B","volume":"31","author":"L Flay","year":"1995","unstructured":"Flay L, Matthews JHL. The effects of radiotherapy and surgery on the sexual function of women treated for cervical cancer. Int J Radiat Oncol Biol Phys. 1995;31(2):399\u2013404. https:\/\/doi.org\/10.1016\/0360-3016(94)E0139-B.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"8274_CR13","first-page":"4433","volume":"34","author":"K Yoshida","year":"2014","unstructured":"Yoshida K, Yamazaki H, Nakamura S, Masui K, Kotsuma T, Akiyama H, et al. Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological Cancer. Anticancer Res. 2014;34(8):4433\u20138.","journal-title":"Anticancer Res"},{"issue":"4","key":"8274_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ijrobp.2012.01.064","volume":"84","author":"V Gondi","year":"2012","unstructured":"Gondi V, Bentzen SM, Sklenar KL, Dunn EF, Petereit DG, Tannehill SP, et al. Severe late toxicities following concomitant Chemoradiotherapy compared to radiotherapy alone in cervical Cancer: an inter-era analysis. Int J Radiat Oncol Biol Phys. 2012;84(4):973\u201382. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.064.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"8274_CR15","first-page":"37","volume":"3","author":"PD Lnskip","year":"1994","unstructured":"Lnskip PD, Eby N, Cookfair D, Freedman RS, Richardson GS, Wactawski-Wende J, et al. Serum estrogen and androgen levels following treatment for cervical Cancer. Cancer Epidemiol Biomark Prev. 1994;3(1):37\u201345.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"8274_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jsxm.2015.12.022","volume":"13","author":"AH Everhov","year":"2016","unstructured":"Everhov AH, R\u00e5destad AF, Nyberg T, Smedby KE, Bergmark K, Hirschberg AL. Serum androgen levels and sexual function before and one year after treatment of uterine cervical Cancer: a pilot study. J Sex Med. 2016;13(3):413\u201324. https:\/\/doi.org\/10.1016\/j.jsxm.2015.12.022.","journal-title":"J Sex Med"},{"issue":"5","key":"8274_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3109\/13697137.2014.946279","volume":"17","author":"DJ Portman","year":"2014","unstructured":"Portman DJ, Gass MLS. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women\u2019s sexual health and the North American Menopause Society. Climacteric. 2014;17(5):557\u201363. https:\/\/doi.org\/10.3109\/13697137.2014.946279.","journal-title":"Climacteric"},{"issue":"1","key":"8274_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/13697137.2013.871696","volume":"17","author":"RE Nappi","year":"2014","unstructured":"Nappi RE, Palacios S. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric. 2014;17(1):3\u20139. https:\/\/doi.org\/10.3109\/13697137.2013.871696.","journal-title":"Climacteric"},{"key":"8274_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/IJWH.S106796","volume":"9","author":"L Morris","year":"2017","unstructured":"Morris L, Do V, Chard J, Brand A. Radiation-induced vaginal stenosis: current perspectives. Int J Women's Health. 2017;9:273\u20139. https:\/\/doi.org\/10.2147\/IJWH.S106796.","journal-title":"Int J Women's Health"},{"key":"8274_CR20","doi-asserted-by":"publisher","unstructured":"Miles T, Johnson N. Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev. 2014;2014(9):CD0072. https:\/\/doi.org\/10.1002\/14651858.CD007291.pub3. PMID: 25198150; PMCID: PMC6513398.","DOI":"10.1002\/14651858.CD007291.pub3"},{"issue":"7","key":"8274_CR21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/GME.0000000000000921","volume":"24","author":"The NAMS 2017 Hormone Therapy Position Statement Advisory Panel","year":"2017","unstructured":"The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 2017;24(7):728\u201353.","journal-title":"Menopause"},{"key":"8274_CR22","doi-asserted-by":"publisher","unstructured":"Denton AS, Maher EJ. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst Rev. 2003;(1):CD003750. https:\/\/doi.org\/10.1002\/14651858.CD003750. PMID: 12535485.","DOI":"10.1002\/14651858.CD003750"},{"key":"8274_CR23","doi-asserted-by":"publisher","unstructured":"Somboonporn W, Davis S, Seif MW, Bell R. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev. 2005;(4):CD004509. https:\/\/doi.org\/10.1002\/14651858.CD004509.pub2. PMID: 16235365.","DOI":"10.1002\/14651858.CD004509.pub2"},{"issue":"7","key":"8274_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/GME.0000000000000613","volume":"23","author":"T Fernandes","year":"2016","unstructured":"Fernandes T, Costa-Paiva LH, Pedro AO, Baccaro LF, Pinto-Neto AM. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial. Menopause. 2016;23(7):792\u20138. https:\/\/doi.org\/10.1097\/GME.0000000000000613.","journal-title":"Menopause"},{"issue":"4","key":"8274_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1634\/theoncologist.2010-0435","volume":"16","author":"S Witherby","year":"2011","unstructured":"Witherby S, Johnson J, Demers L, Mount S, Littenberg B, Maclean CD, et al. Topical testosterone for breast Cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I\/II study. Oncologist. 2011;16(4):424\u201331. https:\/\/doi.org\/10.1634\/theoncologist.2010-0435.","journal-title":"Oncologist"},{"issue":"2","key":"8274_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijgo.2014.02.003","volume":"125","author":"FIGO Committee on Gynecologyc Oncology","year":"2014","unstructured":"FIGO Committee on Gynecologyc Oncology. FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int J Gynaecol Obstet. 2014;125(2):97\u20138. https:\/\/doi.org\/10.1016\/j.ijgo.2014.02.003.","journal-title":"Int J Gynaecol Obstet"},{"key":"8274_CR27","unstructured":"Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology (Report 38-International Commission on Radiation Units & Measurements\/ICRU). 1985. Available at: https:\/\/icru.org\/home\/reports\/dose-and-volume-specification-for-reporting-intracavitary-therapy-in-gynecology-report-38. Accessed 29 Dec 2019."},{"issue":"2","key":"8274_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1148\/99.2.417","volume":"99","author":"RM Pitkin","year":"1971","unstructured":"Pitkin RM, Van Voorhis LW. Postirradiation vaginitis. An avaluation of prophylaxis with topical estrogen. Radiology. 1971;99(2):417\u201321. https:\/\/doi.org\/10.1148\/99.2.417.","journal-title":"Radiology"},{"issue":"1","key":"8274_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/clon.1999.9008","volume":"11","author":"SB Decruze","year":"1999","unstructured":"Decruze SB, Guthrie D, Magnani R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol. 1999;11(1):46\u20138. https:\/\/doi.org\/10.1053\/clon.1999.9008.","journal-title":"Clin Oncol"},{"issue":"6","key":"8274_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/gme.0b013e3181ffde7f","volume":"18","author":"AF Vaz","year":"2011","unstructured":"Vaz AF, Pinto-Neto AM, Conde DM, Costa-Paiva L, Morais SS, Pedro AO, et al. Quality of life and menopausal and sexual symptoms in gynecologic cancer survivors: a cohort study. Menopause. 2011;18(6):662\u20139. https:\/\/doi.org\/10.1097\/gme.0b013e3181ffde7f.","journal-title":"Menopause"},{"issue":"4","key":"8274_CR31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00404-015-3874-z","volume":"293","author":"RC Grion","year":"2016","unstructured":"Grion RC, Baccaro LF, Vaz AF, Costa-Paiva L, Conde DM, Pinto-Neto AM. Sexual function and quality of life in women with cervical cancer before radiotherapy: a pilot study. Arch Gynecol Obstet. 2016;293(4):879\u201386. https:\/\/doi.org\/10.1007\/s00404-015-3874-z.","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"8274_CR32","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3109\/0284186X.2013.818253","volume":"52","author":"JC Lindegaard","year":"2013","unstructured":"Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol. 2013;52(7):1510\u20139. https:\/\/doi.org\/10.3109\/0284186X.2013.818253.","journal-title":"Acta Oncol"},{"issue":"6","key":"8274_CR33","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00404-017-4553-z","volume":"296","author":"J Martins","year":"2017","unstructured":"Martins J, Vaz AF, Grion RC, Esteves SCB, Costa-Paiva L, Baccaro LF. Factors associated with changes in vaginal length and diameter during pelvic radiotherapy for cervical cancer. Arch Gynecol Obstet. 2017;296(6):1125\u201333. https:\/\/doi.org\/10.1007\/s00404-017-4553-z.","journal-title":"Arch Gynecol Obstet"},{"key":"8274_CR34","volume-title":"International guidelines on vaginal dilation after pelvic radiotherapy","author":"International Clinical Guideline Group, National Forum of Gynaecological Oncology Nurses, UK","year":"2012","unstructured":"International Clinical Guideline Group, National Forum of Gynaecological Oncology Nurses, UK. International guidelines on vaginal dilation after pelvic radiotherapy. Oxon: Owen Mumford; 2012."},{"issue":"1","key":"8274_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.radonc.2015.06.018","volume":"116","author":"E Law","year":"2015","unstructured":"Law E, Kelvin JF, Thom B, Riedel E, Tom A, Carter J, et al. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiother Oncol. 2015;116(1):149\u201355. https:\/\/doi.org\/10.1016\/j.radonc.2015.06.018.","journal-title":"Radiother Oncol"},{"issue":"9","key":"8274_CR36","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","volume":"20","author":"Management of symptomatic vulvovaginal atrophy","year":"2013","unstructured":"Management of symptomatic vulvovaginal atrophy. 2013 position statement of the North American Menopause Society. Menopause. 2013;20(9):888\u2013904.","journal-title":"Menopause"},{"issue":"6","key":"8274_CR37","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1067\/mob.2001.119627","volume":"185","author":"JB Gebhart","year":"2001","unstructured":"Gebhart JB, Rickard DJ, Barrett TJ, Lesnick TG, Webb MJ, Podratz KC, et al. Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol. 2001;185(6):1325\u201330. https:\/\/doi.org\/10.1067\/mob.2001.119627.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"8274_CR38","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/gme.0b013e31823b8983","volume":"19","author":"TL Griebling","year":"2012","unstructured":"Griebling TL, Liao Z, Smith PG. Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women. Menopause. 2012;19(6):630\u20135. https:\/\/doi.org\/10.1097\/gme.0b013e31823b8983.","journal-title":"Menopause"},{"key":"8274_CR39","doi-asserted-by":"publisher","unstructured":"Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;2016(8):CD001500. https:\/\/doi.org\/10.1002\/14651858.CD001500.pub3. PMID: 27577677; PMCID: PMC7076628.","DOI":"10.1002\/14651858.CD001500.pub3"},{"issue":"1","key":"8274_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","volume":"118","author":"K Kirchheiner","year":"2016","unstructured":"Kirchheiner K, Nout RA, Lindegaard JC, et al. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio (chemo) therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol. 2016;118(1):160\u20136.","journal-title":"Radiother Oncol"},{"issue":"4","key":"8274_CR41","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.brachy.2015.03.001","volume":"14","author":"HS Park","year":"2015","unstructured":"Park HS, Ratner ES, Lucarelli L, Polizzi S, Higgins SA, Damast S. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma. Brachytherapy. 2015;14(4):464\u201370. https:\/\/doi.org\/10.1016\/j.brachy.2015.03.001.","journal-title":"Brachytherapy"}],"updated-by":[{"DOI":"10.1186\/s12885-021-08543-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000}}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08274-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T08:03:27Z","timestamp":1626336207000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08274-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8274"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08274-w","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12885-021-08543-8","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12885-021-08543-8","URL":"https:\/\/doi.org\/10.1186\/s12885-021-08543-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the University of Campinas Ethics Committee (number 01301512.0.0000.5404) and registered with the Brazilian Registry of Clinical Trials, number NRB-23W5FV. All participants gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"682"}}